Factors influencing medium- and long-term occupational impact following COVID-19. 2024

O O'Sullivan, and A Houston, and P Ladlow, and R M Barker-Davies, and R Chamley, and A N Bennett, and E D Nicol, and D A Holdsworth
Academic Department of Military Rehabilitation (ADMR), Defence Medical Rehabilitation Centre (DMRC), Stanford Hall, Loughborough LE12 5QW, UK.

Significant numbers of individuals struggle to return to work following acute coronavirus disease 2019 (COVID-19). The UK Military developed an integrated medical and occupational pathway (Defence COVID-19 Recovery Service, DCRS) to ensure safe return to work for those with initially severe disease or persistent COVID-19 sequalae. Medical deployment status (MDS) is used to determine ability to perform job role without restriction ('fully deployable', FD) or with limitations ('medically downgraded', MDG). To identify which variables differ between those who are FD and MDG 6 months after acute COVID-19. Within the downgraded cohort, a secondary aim is to understand which early factors are associated with persistent downgrading at 12 and 18 months. Individuals undergoing DCRS had comprehensive clinical assessment. Following this, their electronic medical records were reviewed and MDS extracted at 6, 12 and 18 months. Fifty-seven predictors taken from DCRS were analysed. Associations were sought between initial and prolonged MDG. Three hundred and twenty-five participants were screened, with 222 included in the initial analysis. Those who were initially downgraded were more likely to have post-acute shortness of breath (SoB), fatigue and exercise intolerance (objective and subjective), cognitive impairment and report mental health symptoms. The presence of fatigue and SoB, cognitive impairment and mental health symptoms was associated with MDG at 12 months, and the latter two, at 18 months. There were also modest associations between cardiopulmonary function and sustained downgrading. Understanding the factors that are associated with initial and sustained inability to return to work allows individualized, targeted interventions to be utilized.

UI MeSH Term Description Entries
D008603 Mental Health Emotional, psychological, and social well-being of an individual or group. Mental Hygiene,Health, Mental,Hygiene, Mental
D005221 Fatigue The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli. Lassitude
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D001523 Mental Disorders Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function. Mental Illness,Psychiatric Diseases,Psychiatric Disorders,Psychiatric Illness,Behavior Disorders,Diagnosis, Psychiatric,Mental Disorders, Severe,Psychiatric Diagnosis,Illness, Mental,Mental Disorder,Mental Disorder, Severe,Mental Illnesses,Psychiatric Disease,Psychiatric Disorder,Psychiatric Illnesses,Severe Mental Disorder,Severe Mental Disorders

Related Publications

O O'Sullivan, and A Houston, and P Ladlow, and R M Barker-Davies, and R Chamley, and A N Bennett, and E D Nicol, and D A Holdsworth
January 2022, Frontiers in microbiology,
O O'Sullivan, and A Houston, and P Ladlow, and R M Barker-Davies, and R Chamley, and A N Bennett, and E D Nicol, and D A Holdsworth
June 2023, Western journal of nursing research,
O O'Sullivan, and A Houston, and P Ladlow, and R M Barker-Davies, and R Chamley, and A N Bennett, and E D Nicol, and D A Holdsworth
February 2021, JCO global oncology,
O O'Sullivan, and A Houston, and P Ladlow, and R M Barker-Davies, and R Chamley, and A N Bennett, and E D Nicol, and D A Holdsworth
December 2024, Human vaccines & immunotherapeutics,
O O'Sullivan, and A Houston, and P Ladlow, and R M Barker-Davies, and R Chamley, and A N Bennett, and E D Nicol, and D A Holdsworth
July 2022, Occupational medicine (Oxford, England),
O O'Sullivan, and A Houston, and P Ladlow, and R M Barker-Davies, and R Chamley, and A N Bennett, and E D Nicol, and D A Holdsworth
August 2022, Journal of neurology,
O O'Sullivan, and A Houston, and P Ladlow, and R M Barker-Davies, and R Chamley, and A N Bennett, and E D Nicol, and D A Holdsworth
September 2021, Cureus,
O O'Sullivan, and A Houston, and P Ladlow, and R M Barker-Davies, and R Chamley, and A N Bennett, and E D Nicol, and D A Holdsworth
January 2024, Journal of clinical nursing,
O O'Sullivan, and A Houston, and P Ladlow, and R M Barker-Davies, and R Chamley, and A N Bennett, and E D Nicol, and D A Holdsworth
January 2022, MMW Fortschritte der Medizin,
O O'Sullivan, and A Houston, and P Ladlow, and R M Barker-Davies, and R Chamley, and A N Bennett, and E D Nicol, and D A Holdsworth
January 2024, The journal of allergy and clinical immunology. In practice,
Copied contents to your clipboard!